U.S. flag

An official website of the United States government

NM_014363.6(SACS):c.7539_7540del (p.Cys2514fs) AND Charlevoix-Saguenay spastic ataxia

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003448439.2

Allele description [Variation Report for NM_014363.6(SACS):c.7539_7540del (p.Cys2514fs)]

NM_014363.6(SACS):c.7539_7540del (p.Cys2514fs)

Gene:
SACS:sacsin molecular chaperone [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q12.12
Genomic location:
Preferred name:
NM_014363.6(SACS):c.7539_7540del (p.Cys2514fs)
HGVS:
  • NC_000013.11:g.23336337_23336338del
  • NG_012342.1:g.102366_102367del
  • NM_001278055.2:c.7098_7099del
  • NM_014363.6:c.7539_7540delMANE SELECT
  • NP_001264984.1:p.Cys2367fs
  • NP_055178.3:p.Cys2514fs
  • NC_000013.10:g.23910475_23910476del
  • NC_000013.10:g.23910476_23910477del
Protein change:
C2367fs
Links:
dbSNP: rs1467848128
NCBI 1000 Genomes Browser:
rs1467848128
Molecular consequence:
  • NM_001278055.2:c.7098_7099del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_014363.6:c.7539_7540del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Charlevoix-Saguenay spastic ataxia (SACS)
Synonyms:
Autosomal recessive spastic ataxia of Charlevoix-Saguenay; Spastic ataxia of Charlevoix-Saguenay; SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE
Identifiers:
MONDO: MONDO:0010041; MedGen: C1849140; Orphanet: 98; OMIM: 270550

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004176525Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 14, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Neuberg Centre For Genomic Medicine, NCGM, SCV004176525.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The frame shift c.7539_7540del (p.Cys2514PhefsTer19) variant in SACS gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is reported with the allele frequency (0.0003%) in the gnomAD Exomes and novel in 1000. The variant has been reported as Pathogenic in ClinVar database, but no details are available for independent assessment. This variant causes a frameshift starting with codon Cysteine 2514, changes this amino acid to Phenylalanine residue, and creates a premature Stop codon at position 19 of the new reading frame, denoted p.Cys2514PhefsTer19. Loss of function variants have been previously reported to be disease causing. However, since this variant is present in the last exon, further studies will be required to prove protein truncation. For these reasons, this variant has been classified as Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024